Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y, Hill AP (2012) hERG K(+) Channels: structure, function, and clinical significance. Physiol Rev 92:1393–1478
Article CAS PubMed Google Scholar
Kalyaanamoorthy S, Barakat KH (2018) Development of safe drugs: the hERG challenge. Med Res Rev 38:525–555. https://doi.org/10.1002/med.21445
Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C (2020) hERG Toxicity assessment: useful guidelines for drug design. Eur J Med Chem 195:112290. https://doi.org/10.1016/j.ejmech.2020.112290
Article CAS PubMed Google Scholar
Lester RM, ICH E14, S7B Cardiac Safety Regulations (2021) Update on: the expanded role of preclinical assays and the “double-negative” scenario. Clin Pharmacol Drug Dev 10:964–973. https://doi.org/10.1002/cpdd.1003
Article CAS PubMed PubMed Central Google Scholar
Kratz JM, Grienke U, Scheel O, Mann SA, Rollinger JM (2017) Natural products modulating the hERG channel: heartaches and hope. Nat Prod Rep 34:957–980. https://doi.org/10.1039/c7np00014f
Article CAS PubMed PubMed Central Google Scholar
Villoutreix BO, Taboureau O (2015) Computational investigations of hERG channel blockers: new insights and current predictive models. Adv Drug Deliv Rev 86:72–82. https://doi.org/10.1016/j.addr.2015.03.003
Article CAS PubMed Google Scholar
Krishna S, Borrel A, Huang R, Zhao J, Xia M, Kleinstreuer N (2022) High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition. Biology (Basel) 11:209. https://doi.org/10.3390/biology11020209
Rácz A, Bajusz D, Miranda-Quintana RA, Héberger K (2021) Machine learning models for classification tasks related to drug safety. Mol Divers 25:1409–1424. https://doi.org/10.1007/s11030-021-10239-x
Article CAS PubMed PubMed Central Google Scholar
Braga RC, Alves VM, Silva MFB, Muratov E, Fourches D, Lião LM, Tropsha A, Andrade CH (2015) Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity. Mol Inform 34:698–701. https://doi.org/10.1002/minf.201500040
Article CAS PubMed PubMed Central Google Scholar
Siramshetty VB, Chen Q, Devarakonda P, Preissner R (2018) The catch-22 of predicting hERG blockade using publicly accessible bioactivity data. J Chem Inform Model 58:1224–1233. https://doi.org/10.1021/acs.jcim.8b00150
Cai C, Guo P, Zhou Y, Zhou J, Wang Q, Zhang F, Fang J, Cheng F (2019) Deep learning-based prediction of drug-induced cardiotoxicity. J Chem Inform Model 59:1073–1084. https://doi.org/10.1021/acs.jcim.8b00769
Vachal P, Duffy JL, Campeau L-C, Amin RP, Mitra K, Murphy BA, Shao PP, Sinclair PJ, Ye F, Katipally R, Lu Z, Ondeyka D, Chen Y-H, Zhao K, Sun W, Tyagarajan S, Bao J, Wang S-P, Cote J, Lipardi C, Metzger D, Leung D, Hartmann G, Wollenberg GK, Liu J, Tan L, Xu Y, Chen Q, Liu G, Blaustein RO, Johns DG (2021) Invention of MK-8262, a cholesteryl ester transfer protein (CETP) inhibitor backup to anacetrapib with best-in-class properties. J Med Chem 64:13215–13258. https://doi.org/10.1021/acs.jmedchem.1c00959
Article CAS PubMed Google Scholar
van Veldhoven JPD, Campostrini G, van Gessel CJE, Ward-van Oostwaard D, Liu R, Mummery CL, Bellin M, IJzerman AP (2021) Targeting the Kv11.1 (hERG) channel with allosteric modulators. Synthesis and biological evaluation of three novel series of LUF7346 derivatives. Eur J Med Chem 212:113033. https://doi.org/10.1016/j.ejmech.2020.113033
Article CAS PubMed Google Scholar
Leung KM, Elashoff RM, Afifi AA (1997) Censoring issues in survival analysis. Annu Rev Public Health 18:83–104. https://doi.org/10.1146/annurev.publhealth.18.1.83
Article CAS PubMed Google Scholar
Wei LJ (1992) The accelerated failure time model: a useful alternative to the cox regression model in survival analysis. Stat Med 11:1871–1879. https://doi.org/10.1002/sim.4780111409
Article CAS PubMed Google Scholar
Sheridan RP (2012) Three useful dimensions for domain applicability in QSAR models using random forest. J Chem Inform Model 52:814–823. https://doi.org/10.1021/ci300004n
Sheridan RP, Wang WM, Liaw A, Ma J, Gifford EM (2016) Extreme gradient boosting as a method for quantitative structure-activity relationships. J Chem Inform Model 56:2353–2360. https://doi.org/10.1021/acs.jcim.6b00591
Didziapetris R, Lanevskij K (2016) Compilation and physicochemical classification analysis of a diverse hERG inhibition database. J Comput Aided Mol Des 30:1175–1188. https://doi.org/10.1007/s10822-016-9986-0
Article CAS PubMed Google Scholar
Chen X-L, Kang J, Rampe D (2011) Manual whole-cell patch-clamping of the HERG cardiac K + channel. Methods Mol Biol 691:151–163. https://doi.org/10.1007/978-1-60761-849-2_9
Article CAS PubMed Google Scholar
Sorota S, Zhang X-S, Margulis M, Tucker K, Priestley T (2005) Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen. Assay Drug Dev Technol 3:47–57. https://doi.org/10.1089/adt.2005.3.47
Article CAS PubMed Google Scholar
Schupp M, Park SH, Qian B, Yu W (2020) Electrophysiological studies of GABAA receptors using QPatch II, the next generation of automated patch-clamp instruments. Curr Protoc Pharmacol 89:e75. https://doi.org/10.1002/cpph.75
Article CAS PubMed Google Scholar
Murphy SM, Palmer M, Poole MF, Padegimas L, Hunady K, Danzig J, Gill S, Gill R, Ting A, Sherf B, Brunden K, Stricker-Krongrad A (2006) Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel. J Pharmacol Toxicol Methods 54:42–55. https://doi.org/10.1016/j.vascn.2005.10.003
Article CAS PubMed Google Scholar
Chiu PJS, Marcoe KF, Bounds SE, Lin C-H, Feng J-J, Lin A, Cheng F-C, Crumb WJ, Mitchell R (2004) Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K + channels. J Pharmacol Sci 95:311–319
Article CAS PubMed Google Scholar
Raab CE, Butcher JW, Connolly TM, Karczewski J, Yu NX, Staskiewicz SJ, Liverton N, Dean DC, Melillo DG (2006) Synthesis of the first sulfur-35-labeled hERG radioligand. Bioorg Med Chem Lett 16:1692–1695. https://doi.org/10.1016/j.bmcl.2005.12.021
Article CAS PubMed Google Scholar
Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contribution and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717
Article CAS PubMed Google Scholar
Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623
Article CAS PubMed Google Scholar
Choi K-H, Song C, Shin D, Park S (2011) hERG channel blockade by externally applied quaternary ammonium derivatives. Biochim Biophys Acta 1808:1560–1566. https://doi.org/10.1016/j.bbamem.2011.02.008
Article CAS PubMed Google Scholar
Bridgland-Taylor MH, Hargreaves AC, Easter A, Orme A, Henthorn DC, Ding M, Davis AM, Small BG, Heapy CG, Abi-Gerges N, Persson F, Jacobson I, Sullivan M, Albertson N, Hammond TG, Sullivan E, Valentin J-P, Pollard CE (2006) Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT. J Pharmacol Toxicol Methods 54:189–199. https://doi.org/10.1016/j.vascn.2006.02.003
Article CAS PubMed Google Scholar
Chen T, Guestrin C (2016) XGBoost: A Scalable Tree Boosting System. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. pp 785–794
Barnwal A, Cho H, Hocking T (2022) Survival regression with accelerated failure time model in XGBoost. J Comput Graph Stat. https://doi.org/10.1080/10618600.2022.2067548
McFadden D (1974) Conditional logit analysis of qualitative choice behavior. In: Zarembka P (ed) Frontiers in econometrics. Academic Press, New York, pp 105–142
Cox DR, Snell EJ (1989) Analysis of binary data, 2nd edn. Chapman and Hall, London, UK
Veall MR, Zimmermann KF (1994) Evaluating Pseudo-R2’s for binary probit models. Qual Quant 28:151–164. https://doi.org/10.1007/BF01102759
Hemmert GAJ, Schons LM, Wieseke J, Schimmelpfennig H (2018) Log-likelihood-based Pseudo-R2 in logistic regression: deriving sample-sensitive benchmarks. Sociol Methods Res 47:507–531. https://doi.org/10.1177/0049124116638107
Powers D (2011) Evaluation: From precision, recall and f-measure to roc., informedness, markedness & correlation. J Mach Learn Technol 2:37–63
Chicco D, Jurman G (2020) The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics 21:6. https://doi.org/10.1186/s12864-019-6413-7
Article PubMed PubMed Central Google Scholar
Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27:861–874. https://doi.org/10.1016/j.patrec.2005.10.010
Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37:360–363
Czodrowski P (2014) Count on kappa. J Comput Aided Mol Des 28:1049–1055. https://doi.org/10.1007/s10822-014-9759-6
留言 (0)